Anju Starace
Overview
Explore the profile of Anju Starace including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
214
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ketter T, Sachs G, Durgam S, Lu K, Starace A, Laszlovszky I, et al.
J Affect Disord
. 2017 Aug;
225:350-356.
PMID: 28843918
Background: We evaluated the safety/tolerability of longer-term open-label treatment with cariprazine in patients who had responded to cariprazine for acute bipolar mania. Methods: In this multinational, multicenter study, open-label, flexible-dose,...
2.
Calabrese J, Keck Jr P, Starace A, Lu K, Ruth A, Laszlovszky I, et al.
J Clin Psychiatry
. 2015 Jan;
76(3):284-92.
PMID: 25562205
Objective: This phase 3 trial evaluated the efficacy, safety, and tolerability of low- and high-dose cariprazine in patients meeting DSM-IV-TR criteria for acute manic or mixed episodes associated with bipolar...
3.
Sachs G, Greenberg W, Starace A, Lu K, Ruth A, Laszlovszky I, et al.
J Affect Disord
. 2014 Dec;
174:296-302.
PMID: 25532076
Background: This Phase III, randomized, double-blind, placebo-controlled study investigated the efficacy and tolerability of flexibly-dosed cariprazine in patients with acute manic or mixed episodes associated with bipolar I disorder. Methods:...
4.
Durgam S, Starace A, Li D, Migliore R, Ruth A, Nemeth G, et al.
Bipolar Disord
. 2014 Jul;
17(1):63-75.
PMID: 25056368
Objectives: Cariprazine, an orally active and potent dopamine D3 and D2 receptor partial agonist with preferential binding to D3 receptors, is being developed for the treatment of schizophrenia and bipolar...
5.
Durgam S, Starace A, Li D, Migliore R, Ruth A, Nemeth G, et al.
Schizophr Res
. 2014 Jan;
152(2-3):450-7.
PMID: 24412468
Introduction: Cariprazine is an orally active and potent D3 and D2 partial agonist with preferential binding to D3 receptors in development for the treatment of schizophrenia and bipolar mania. This...